Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2014; 60(2): 75-81


Renoprotective efficacy of different doses of statins in experimental acute renal failure

Zeleniuk VH, Zamors'kyĭ II, Horoshko OM.

    Bukovinsky Medical University, Ministry of Public Health, Ukraine
DOI: https://doi.org/10.15407/fz60.02.075

Abstract

The effect of three statins (atorvastatin, lovastatin, simvastatin) on the renal function under conditions of experimental acute renal failure in rats was studied. The relatively effective doses were found to possess the most considerable renoprotective properties. All the statins were established to cause the restoration of functional activity of the kidneys under conditions of experimental rhabdomyolytic acute renal failure at various doses, but with the dose of 20 mg/kg they showed the most significant improvement in key indices of kidney function: an increase in diuresis by an average of 32% and glomerular filtration rate by an average of 90%, reduction of proteinuria in more than twice. At the same time, in the animals with acute renal failure the level of creatine phosphokinase was increased by 141%. However, the activity of blood plasma creatine phosphokinase of all animals treated with statins was 14% higher than in the intact control, indicating the minor myotrphic activity of statins in selected mode of administration. Thus, the use of 20 mg/kg dose is the most reasonable from the standpoint of renoprotective efficacy and safety

Keywords: acute renal failure, statins, renoprotection, creatinephosphokinase.

References

  1. D'Amico G. Statins and renal diseases: from primary prevention to renal replacement therapy. J. Am. Soc. Nephrol. 2006; 17: S148-S152. CrossRef   PubMed
  2.  
  3. Epstein M., Campese V.M. Pleiotropic effects of 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitors on renal function. Am. J. Kidney Dis. 2005; 45: 2-14. CrossRef
  4.  
  5. Tonelli M. Do statins protect the kidney as well as the heart? Cardiology rounds. 2006; Vol. 10, Iss. 6: 171-173.
  6.  
  7. Navaneethan S.D., Pansini F., Perkovic V. et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis (Review). The Cochrane Library. 2009; Iss. 3.
  8.  
  9. Atroshchenko E.S. Pleiotropic effects of statins: new aspects of the action of HMG-CoA reductase inhibitors. Medical news. 2004; 3: 59-66.
  10.  
  11. Nesic Z. Acute protective effects of different doses of simvastatin in the rat model of renal ischemia-reperfusion injury. Acta Vet-Beograd. 2008; Vol. 58, 5-6: 413-427.
  12.  
  13. Shtrygol S.Iu., Lisovyi V.M., Zupanets I.A. et al. Methods of experimental simulation of the kidney injury in the pharmacological studies: Methodological recommendations of the SPU of the HC of Ukraine. Kyiv; 2009. s.9-10.
  14.  
  15. Law M.R., Wald N.J., Rudnicka A.R. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and metaanalysis.BMJ. 2003; Vol. 326: 1-7. CrossRef PubMed PubMedCentral
  16.  
  17. Ozbek E., Cekmen M., Ilbey Y.O. et al. Atorvastatin prevents gentamicin-induced renal damage in rats through the inhibition of p38-MAPK and NF-kappaB pathways. Ren. Fail. 2009; 31(5): 382-392. CrossRef PubMed
  18.  
  19. Issabeagloo E., Gharamaleki M.N., Kermanizadeh P., Abri B. Effect of lovastatin in prevention of renal lesions due to complete unilateral urethral obstruction in rats. Am. J. Sci. Res. 2012; 72: 89-98.
  20.  
  21. Jabbari M., Rostami Z., Jenabi A. et al. Simvastatin ameliorates gentamicin-induced injury in rats. Saudi. J. Kid. Dis. Transp. 2011; Vol. 22, Iss. 6: 1181-1186. PubMed
  22.  
  23. European convention for the protection of the vertebrateanimals used for experimental and other scientific purpose: Council of Europe 18.03.1986. Strasbourg, 1986.
  24.  
  25. Riabov S.I., Natochin Iu.V. Phunctional nephrology. Saint Petersburg: Lan', 1997.
  26.  
  27. Mikheeva A.I., Bogodarova I.A. Methods of determining the total protein in the urine on the photoelectric colorimeter. Lab. delo. 1969; 7: 441-442.
  28.  
  29. Berkhin E.B., Ivanov Iu.I. Methods of experimental study of the kidney and water-salt metabolism. Barnaul; 1972.
  30.  
  31. Schettler G., Nussel E. Determination of triglycerides. Arbeitsmed.Sozialmed. Chol. Praventiv. Med. 1975; 10: 25.
  32.  
  33. Goriachkovskii A.M. Clinical biochemistry. Odessa: Astroprint; 1998.
  34.  
  35. Ueda I., Wada T. Determination of inorganic phosphate by the molybdovanadate method in the presence of ATP and some interfering organic bases. Anal. Biochem. 1970;Vol. 37, Iss. 1: 169-174. CrossRef
  36.  

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2019.